| Application no. and date | 13176200.7 (espacenet) (Federated) (European Patent Register), 20060914 | | Patent/reg. no. and date | DK/EP 2656836, 20170726 | | Publication date | 20131030 | | Priority no. and date | US 717524 P, 20050914, US 744882 P, 20060414 | | EP pub. no. and date |
EP 2656836 20131030 | | Effective date | | | Applicant/owner | MannKind Corporation, 25134 Rye Canyon Loop, Suite 300
Valencia, CA 91355, US | | Applicant ref. no. | LU-PV-272537/EP-DK-IMH | | Inventor | Oberg, Keith A, El Gato Place
Valencia, CA California 91355, US | | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , A61K 9/16 (2006.01) | | Title | Fremgangsmåde til lægemiddelformulering baseret på øgning af krystallinske mikropartikeloverfladers affinitet for aktive midler | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
